Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

od Møller Pål
Wydane 2004-12-01

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

od Møller, Pål
Wydane 2004

The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care

od Møller, Pål
Wydane w Hered Cancer Clin Pract (2020)

The BRCA2 variant c.68-7 T>A is associated with breast cancer

od Møller, Pål, Hovig, Eivind
Wydane w Hered Cancer Clin Pract (2017)

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

od Møller, Pål, Hovig, Eivind
Wydane w Hered Cancer Clin Pract (2018)

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

od Møller, Pål, Hovig, Eivind
Wydane w Med Health Care Philos (2017)

Costs and Benefits of Diagnosing Familial Breast Cancer

od Heimdal, Ketil, Mæhle, Lovise, Møller, Pål
Wydane 1999

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

od Tharmaratnam, Kukatharmini, Hagen, Anne Irene, Møller, Pål
Wydane w Breast Cancer Res Treat (2014)

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers

od Møller, Pål, Mæhle, Lovise, Clark, Neal, Apold, Jaran
Wydane 2007

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations

od Reichelt, Jon G., Dahl, Alv A., Heimdal, Ketil, Møller, Pål
Wydane 1999

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift

od Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Wydane w Cancers (Basel) (2019)

Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11...

od Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Wydane w Cancers (Basel) (2020)

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

od Seppälä, Toni T., Dominguez-Valentin, Mev, Sampson, Julian R., Møller, Pål
Wydane w Fam Cancer (2020)

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer

od Stormorken, Astrid, Heintz, Karen-Marie, Andresen, Per Arne, Hovig, Eivind, Møller, Pål
Wydane 2006

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

od Borg, Åke, Dørum, Anne, Heimdal, Ketil, Mæhle, Lovise, Hovig, Eivind, Møller, Pål
Wydane 1999

Survival in Norwegian BRCA1 mutation carriers with breast cancer

od Hagen, Anne Irene, Tretli, Steinar, Mæhle, Lovise, Apold, Jaran, Vedå, Nina, Møller, Pål
Wydane 2009

Ten modifiers of BRCA1 penetrance validated in a Norwegian series

od Heramb, Cecilie, Ekstrøm, Per Olaf, Tharmaratnam, Kukatharmini, Hovig, Eivind, Møller, Pål, Mæhle, Lovise
Wydane w Hered Cancer Clin Pract (2015)

Germline PTEN mutations are rare and highly penetrant

od Rustad Cecilie F, Bjørnslett Merete, Heimdal Ketil R, Mæhle Lovise, Apold Jaran, Møller Pål
Wydane 2006-12-01

Germline PTEN mutations are rare and highly penetrant

od Rustad, Cecilie F, Bjørnslett, Merete, Heimdal, Ketil R, Mæhle, Lovise, Apold, Jaran, Møller, Pål
Wydane 2006

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

od Møller, Pål, Stormorken, Astrid, Holmen, Marit Muri, Hagen, Anne Irene, Vabø, Anita, Mæhle, Lovise
Wydane 2014